Bristol-Myers Squibb Co. of New York has appointed Leon E. Rosenberg, formerly C.N.H. Long Professor of Genetics at Yale University and dean of Yale's School of Medicine, as president of the Bristol-Myers Squibb Pharmaceutical Research Institute. His appointment became effective yesterday.
Rosenberg, who never worked in industry before joining Bristol-Myers Squibb, says that the opportunity "came very much out of the blue--there was no plan for me to leave Yale to go anywhere." The 58-year-old former dean says he decided to take the job because "I found myself fascinated by the challenge and by the change in perspective. It's an opportunity to climb one more big hill."
At Yale, Rosenberg's research focused on inherited metabolic disorders in children. His group discovered that children with a potentially lethal disorder of organic acid metabolism suffer from defective metabolism of vitamin B-12 (Biochem. Biophys. Res. Commun., 37:607, 1969; 44:375, 1971; Pediatrics, 26:497, 1970). ...
